Potential function | Gene (Fold change) | Annotation |
---|---|---|
Matrix protein | VCAN (1.55) | Versican, chondroitin sulfate proteoglycan, calcium ion binding |
 | CDH6 (1.71) | Cadherin 6, calcium binding, in association with the physiological control of bone remodeling |
 | LOC107056462 (1.61) | Alpha-actinin-1-like, calcium binding |
 | PLCL1 (1.61) | Phospholipase C like 1, calcium binding |
 | OVAL (1.52) | Ovalbumin, regulate shell structure and present in eggshell |
 | GPC3 (0.64) | Glypican 3, regulate the activity of bone morphogenetic proteins and promote bone formation |
 | DMP1 (0.66) | Dental matrix protein-1, in association with tissue mineralization |
Calcium transport | CACNA1C (1.79) | Voltage-dependent L-type calcium channel subunit alpha-1C, ion transport protein, voltage-gated calcium channel activity |
 | CACNA1D (1.68) | Voltage-dependent L-type calcium channel subunit alpha-1D, ion transport protein, voltage-gated calcium channel activity |
 | NMUR2 (1.52) | Thyrotropin-releasing hormone receptor, calcium ion transport |
Immune response | BF2 (0.66) | MHC class I antigen BF2, antigen processing and presentation |
 | MHCIA5 (0.58) | Major histocompatibility complex, class I, A5, antigen processing and presentation |
 | MHCIA6 (0.62) | Major histocompatibility complex, class I, A6, antigen processing and presentation |
 | YF5 (0.64) | MHC class I antigen YF5, antigen processing and presentation |
 | LOC101748499 (1.64) | Class II histocompatibility antigen, B-L beta chain-like, immune response |
 | IL7 (1.63) | Interleukin 7, a cytokine important for B and T cell development |
 | C7 (1.61) | Complement C7, as part of the terminal complement pathway of the innate immune system |
 | KCTD7 (1.71) | Potassium channel tetramerization domain containing 7, negative regulation of inflammation |
Defense mechanism | ABCA13 (1.65) | ATP-binding cassette, sub-family A, membrane 13, defense mechanism |
 | LOC107056420 (1.50) | Intestinal mucin-like protein, defense mechanism |